The global cryopreservation cell lines market size was valued at USD 3.77 billion in 2025 and is projected to grow from USD 4.19 billion in 2026 to USD 9.75 billion by 2034, registering a CAGR of 11.14% during the forecast period (2026-2034). North America dominated the cryopreservation cell lines market with a share of 40.72% in 2025.
Cryopreservation cell lines refer to the products, materials, and systems used to preserve living cell lines at ultra low temperatures while maintaining their viability, and ability to recover after thawing. These products for cell lines are commonly classified under HSN Code 3824 (prepared chemical products and preparations of the chemical or allied industries) and SIC Code 2836 (Biological Products, Except Diagnostic Substances).
The cryopreservation cell lines market demand is driven by growing biotechnology research, and the need for reliable long term storage of biological materials. Research laboratories and biopharmaceutical manufacturers are increasingly using serum free freezing media, cryoprotective agents and automated cell preservation technologies to improve post thaw cell recovery and maintain consistent cell quality.
Download a Free Sample To learn more about this report,
Shift toward Serum Free Cryopreservation Media
The cryopreservation cell lines market analysis shows shift towards serum free cryopreservation media to improve consistency and reduce reliance on animal derived components during cell storage. This trend is supporting more standardized cell banking processes and increasing the suitability of cryopreservation methods for biopharmaceutical research and cell line development.
Growth of Automated Cell Cryopreservation Systems
Cryopreservation cell lines market is witnessing growth in automated cell cryopreservation systems as laboratories and biopharmaceutical manufacturers seek greater accuracy. This development is improving operational efficiency, supporting reproducible cell recovery, and helping organizations manage larger cell banks for research and commercial production.
Supply chain disruptions are expected to have a high impact on the cryopreservation cell lines market share due to dependence on specialized cryopreservation media, cell culture reagents, and liquid nitrogen storage. The market is expected to follow a stair-step recovery, as shortages of cryopreservation materials, and disruptions in cold chain transportation can affect cell banking and storage operations in phases before material availability and distribution capacity stabilize. The market is expected to grow at a CAGR of 11.14%, but supply chain constraints could approximately lower this by 1.2 percentage points, resulting in short term growth of around 9.94%. As supply conditions normalize, the cryopreservation cell lines market growth is expected to gradually return to 11.14%.
The cryopreservation cell lines market forecasts strategic investment activity driven by development of DMSO free preservation media, advancement of room temperature cell storage technologies and growing demand for reliable long term cell preservation and storage solutions. In September 2026, ARPA-H announced funding of up to USD 87 million across four year contracts to develop room temperature preservation methods for cell based medicines and other biologic products, potentially reducing dependence on cold chain storage.
Demand for Reliable Cell Viability After Thawing and Need for Long Term Cell Line Storage Drives Market
Demand for reliable cell viability after thawing is growing as researchers need healthy cells for testing and experiments. Effective cryopreservation methods help maintain cell quality and function during freezing and thawing. This reduces cell loss and supports more consistent research results, driving demand for cryopreservation cell line products.
Need for long term cell line storage is growing as research laboratories and biopharmaceutical companies require reliable ways to preserve cells for future use. Cryopreservation helps maintain cell quality over extended periods and reduces the need for repeated cell cultivation. This allows researchers to access stored cells for drug testing, experiments, and product development.
Risk of Cell Contamination During Cryopreservation and Dependence on Specialized Cryopreservation Media Restraints Market Expansion
Risk of cell contamination during cryopreservation can affect the quality and reliability of stored cell lines. Contamination may occur during cell handling, sample preparation, freezing, or storage due to inadequate sterile conditions or improper laboratory practices. These issues can increase operational costs and create delays in research and biopharmaceutical development, thereby restraining market growth.
Dependence on specialized cryopreservation media can increase the complexity and cost of preserving cell lines. Different cell lines may require specific media formulations to maintain cell viability and functionality after thawing. The need for specialized formulations, and suitable storage conditions can increase procurement and validation costs for laboratories and biopharmaceutical manufacturers.
Expansion of Cryopreserved Cell Lines in Biobanking and Reference Cell Collection Offers Growth Opportunities
The need to preserve biological materials for long term research is creating opportunities for cryopreservation providers to serve biobanks, academic institutions, and pharmaceutical research laboratories. Revenue can be generated through cell line supply, storage services, specialized preservation media, and biobanking contracts, contributing to cryopreservation cell lines market growth.
Use of cell based assays in drug development is creating opportunities for suppliers to serve biotechnology companies, contract research organizations, and pharmaceutical laboratories. Revenue can be generated through standardized cell products, assay ready cell line supply, customized preparation services, and research partnerships, supporting market growth.
The cell freezing media segment accounted for a share of 44.6% in 2025, reflecting its essential role in protecting cells from freezing related damage and maintaining cell viability during storage and thawing.
Consumables segment is projected to register a CAGR of 11.58% during the forecast period, supported by recurring demand for cryogenic vials, storage containers, and other supplies required for safe cell preservation, handling, and storage.
Request Customizationto receive a tailored report.
Stem cells accounted for a share of 35.8% in 2025, owing to the growing use of stem cells in regenerative medicine, disease modeling, and drug discovery, which requires reliable long term preservation.
Bioproduction cell lines segment is expected to achieve a CAGR of 11.84% during the forecast period, driven by increasing demand for cell lines used in biologics manufacturing, including vaccines, therapeutic proteins, and monoclonal antibodies.
Biopharmaceutical & pharmaceutical companies accounted for a share of 39.4% in 2025, reflecting their extensive need for preserved cell lines in drug discovery, biologics development, and manufacturing processes.
Biobanks segment is estimated to register a growth rate of 11.43% during the forecast period, driven by the demand for long term storage of biological samples and cell lines for research, disease studies, and future therapeutic applications.
Speak to an Analystto discuss market opportunities.
The North America cryopreservation cell lines market accounted for a share of 40.72% in 2025.
The U.S. market benefits from the National Institutes of Health (NIH) cell culture research ecosystem, which supports biomedical studies involving mammalian cells. Continued research activity is strengthening demand for reliable preservation methods that maintain the viability and stability of mammalian cell lines for experiments and drug development.
Canada’s Stem Cell Network supports stem cell and regenerative medicine research through funding, training, and collaboration. This research activity is supporting demand for reliable cell culture and cryopreservation methods that help preserve cell samples for ongoing laboratory studies and therapeutic research.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific cryopreservation cell lines market is projected to grow at a CAGR of 13.06% during the forecast period, making it the fastest growing region.
China’s China National GeneBank (CNGB) supports the collection, storage, and use of biological resources for research. Expansion of these activities is supporting demand for biobanking and reliable cryopreservation methods that maintain cell viability for long term research use.
In Japan, Act on the Safety of Regenerative Medicine provides a regulatory framework for medical practices involving regenerative medicine. This is supporting development of cell therapy research and treatment programs that require carefully controlled cell storage and preservation.
India’s National Biopharma Mission, implemented through BIRAC, drives biotechnology research and development, including advanced biopharmaceutical products. Activity in regenerative medicine and cell based research is strengthening demand for tissue preservation and cryopreservation techniques that maintain biological samples for further study and therapeutic development.
The Europe cryopreservation cell lines marketis expected to achieve a growth rate of 10.34% during the forecast period.
German Biobank Network (GBN) connects biobanks that collect and store human biological samples for research. These activities support demand for liquid nitrogen storage and controlled low temperature preservation systems that help maintain sample quality over extended periods.
UK Biobank maintains a large collection of biological samples for health research. Its long term sample storage activities support the need for reliable frozen cell stocks and standardized preservation procedures that help retain sample integrity for future analysis.
Latin America's cryopreservation cell lines market is expected to grow at a CAGR of 9.86% during the forecast period. Research conducted at the University of São Paulo Medical School in Brazil has examined freezing methods and cryoprotectants for preserving human amniotic fluid stem cells.
In Mexico, National Autonomous University of Mexico (UNAM) has research groups working on stem cell biology and regenerative medicine, including studies involving the isolation, culture, and characterization of stem cells. These activities support demand for reliable cryogenic storage anfd regenerative medicine methods that maintain cell viability.
The Middle East & Africa cryopreservation cell lines market is expected to grow at a CAGR of 9.42% during the forecast period. Researchers at New York University Abu Dhabi (NYU Abu Dhabi) developed a paper based technology for cryopreserving mammalian cells and 3D tumor models.
In South Africa, Clinical Laboratory for Experimental and Analytical Research (CLEAR) at the Perinatal HIV Research Unit provides peripheral blood mononuclear cell processing and cryopreservation services for clinical research. These capabilities support pharmaceutical research and biotechnology research involving vaccine efficacy, drug monitoring, and immune response studies by helping maintain biological samples for laboratory analysis.
The cryopreservation cell lines market competitive landscape is highly fragmented, with established life sciences companies, cell preservation solution providers, laboratory equipment manufacturers, and biotechnology suppliers. Key players such as Thermo Fisher Scientific Inc., Merck KGaA, BioLife Solutions Inc., Corning Incorporated, and Lonza Group Ltd. are estimated to account for approximately 30–35% of the global cryopreservation cell lines market share.
Established players compete mainly through cryopreservation media formulations, cell viability preservation, storage technologies, laboratory consumables, quality control, and biopharmaceutical manufacturing support. Emerging and regional players in the cryopreservation cell lines market ecosystem focus on specialized preservation solution, and application specific cell preservation products.
September 2026: Thermo Fisher Scientific launched Gibco™ CHO-K1 catalog media and feed products to support cell line development and improve efficiency in biologics development.
April 2026: Thermo Fisher Scientific introduced an integrated platform for scalable cell therapy manufacturing.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Experts
The Straits Research Team is a group of experienced researchers, analysts, and industry professionals dedicated to delivering reliable, insightful, and well-structured market intelligence. With expertise across multiple sectors and domains, the team combines extensive research, data analysis, and industry knowledge to provide a clear understanding of evolving markets and business environments.
The team focuses on identifying key market trends, emerging opportunities, technological developments, competitive landscapes, and changing industry dynamics. Through a thoughtful and research-driven approach, it aims to provide valuable insights that help businesses, investors, and decision-makers better understand their industries and make informed strategic decisions.
Cell Therapy Growth Factor Market Size, Forecast, Demand, 2034
Biologics Contract Manufacturing Market Size, Forecast, 2034
Antibody Purification Service Market Size, Forecast, Demand, Opportunities, 2034
Red Biotechnology Market Size, Share, Growth, Forecast, 2034
Cell Culture Market Size, Share, Growth, Analysis, Report, 2034
Cell Line Development Services Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com